Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by u2bobon Mar 14, 2018 11:10am
128 Views
Post# 27713131

RE:POSITIVE NEWS

RE:POSITIVE NEWS
frewil11 wrote: This is good news but I sure wish they could have signed up alot more than just 1 clinic.


Instead of looking at the glass half empty... you could read between the lines...and start topping off your glass...lol...

Chaparral Medical Group has decided it will automatically include eye screening using our CARA platform for diabetic and pre-diabetic patient at their annual visit.

Chaparral is introducing AI to enhance the overall value of the annual health examination to Medicare members by encompassing CARA as an additional screening test for the annual wellness program.

I look at it this way they are sold on our product ...but more importantly like Mexico they are doing annual screening which is great repeat customers plus any new clients...win win..so to me this is a great show of confidence in our product ...so we keep plugging along adding more and more sites as we go spreading out a network then Blockchain... Cardio and so forth....

Good Luck
Bob

 


Bullboard Posts